ED, C., J, P., N, H., O, B., KL, L., AJ, L., . . . AP, P. (2023). Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study. Alzheimer's & dementia (New York, N. Y.), 9(3), e12403. https://doi.org/10.1002/trc2.12403
Chicago Style (17th ed.) CitationED, Clark, et al. "Effects of Methylphenidate on Neuropsychiatric Symptoms in Alzheimer's Disease: Evidence from the ADMET 2 Study." Alzheimer's & Dementia (New York, N. Y.) 9, no. 3 (2023): e12403. https://doi.org/10.1002/trc2.12403.
MLA (9th ed.) CitationED, Clark, et al. "Effects of Methylphenidate on Neuropsychiatric Symptoms in Alzheimer's Disease: Evidence from the ADMET 2 Study." Alzheimer's & Dementia (New York, N. Y.), vol. 9, no. 3, 2023, p. e12403, https://doi.org/10.1002/trc2.12403.